中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
22期
198-200,212
,共4页
张金梁%刘方伶%牛宝军%张青山%康艳艳%陈建茹%杨凤莲%曾兆荣%程少春
張金樑%劉方伶%牛寶軍%張青山%康豔豔%陳建茹%楊鳳蓮%曾兆榮%程少春
장금량%류방령%우보군%장청산%강염염%진건여%양봉련%증조영%정소춘
高血压性脑出血%微创治疗%软通道
高血壓性腦齣血%微創治療%軟通道
고혈압성뇌출혈%미창치료%연통도
Hypertensive intracerebral hemorrhage%Minimally invasive treatment%Soft channel
目的:探讨高血压性基底节区脑出血微创软通道治疗的效果。方法选取2008年3月~2012年3月我院收治的106例高血压性基底节区脑出血患者,将其随机分为微创软通道治疗组(53例)和小骨窗血肿清除治疗组(53例)。观察两组的总体治疗有效率、死亡率以及3个月后的ADL分级状况。结果微创软通道治疗组的总体治疗有效率为92.45%,显著高于小骨窗血肿清除治疗组的71.70%(P<0.05);微创软通道治疗组的死亡率为3.77%,显著小于小骨窗血肿清除治疗组的9.43%(P<0.05);微创软通道治疗组3个月后的日常生活功能评定(ADL),Ⅰ级30例,Ⅱ级11例,Ⅲ级5例,Ⅳ~Ⅴ级5例,小骨窗血肿清除治疗组的日常生活功能评定(ADL),Ⅰ级15例,Ⅱ级18例,Ⅲ级10例,IV~V级5例。结论在严格掌握手术适应证的前提下,经微创钻孔治疗高血压性基底节区脑出血可有效清除颅内血肿,从而减轻脑组织水肿,操作简单、安全,可显著改善患者预后,降低致死、致残率。
目的:探討高血壓性基底節區腦齣血微創軟通道治療的效果。方法選取2008年3月~2012年3月我院收治的106例高血壓性基底節區腦齣血患者,將其隨機分為微創軟通道治療組(53例)和小骨窗血腫清除治療組(53例)。觀察兩組的總體治療有效率、死亡率以及3箇月後的ADL分級狀況。結果微創軟通道治療組的總體治療有效率為92.45%,顯著高于小骨窗血腫清除治療組的71.70%(P<0.05);微創軟通道治療組的死亡率為3.77%,顯著小于小骨窗血腫清除治療組的9.43%(P<0.05);微創軟通道治療組3箇月後的日常生活功能評定(ADL),Ⅰ級30例,Ⅱ級11例,Ⅲ級5例,Ⅳ~Ⅴ級5例,小骨窗血腫清除治療組的日常生活功能評定(ADL),Ⅰ級15例,Ⅱ級18例,Ⅲ級10例,IV~V級5例。結論在嚴格掌握手術適應證的前提下,經微創鑽孔治療高血壓性基底節區腦齣血可有效清除顱內血腫,從而減輕腦組織水腫,操作簡單、安全,可顯著改善患者預後,降低緻死、緻殘率。
목적:탐토고혈압성기저절구뇌출혈미창연통도치료적효과。방법선취2008년3월~2012년3월아원수치적106례고혈압성기저절구뇌출혈환자,장기수궤분위미창연통도치료조(53례)화소골창혈종청제치료조(53례)。관찰량조적총체치료유효솔、사망솔이급3개월후적ADL분급상황。결과미창연통도치료조적총체치료유효솔위92.45%,현저고우소골창혈종청제치료조적71.70%(P<0.05);미창연통도치료조적사망솔위3.77%,현저소우소골창혈종청제치료조적9.43%(P<0.05);미창연통도치료조3개월후적일상생활공능평정(ADL),Ⅰ급30례,Ⅱ급11례,Ⅲ급5례,Ⅳ~Ⅴ급5례,소골창혈종청제치료조적일상생활공능평정(ADL),Ⅰ급15례,Ⅱ급18례,Ⅲ급10례,IV~V급5례。결론재엄격장악수술괄응증적전제하,경미창찬공치료고혈압성기저절구뇌출혈가유효청제로내혈종,종이감경뇌조직수종,조작간단、안전,가현저개선환자예후,강저치사、치잔솔。
ObjectiveTo explore the effect of minimally invasive soft channel in treatment of hypertensive basal ganglia hemorrhage.Methods Selected 106 cases of hypertensive basal ganglia hemorrhage patients in our hospital from March 2008 to March 2012,and randomly divided into minimally invasive soft-channel treatment group (53 cases) and a small bone window hematoma treatment group (53 cases). Two groups of the overall efficiency of the treatment, mortality and ADL classification status after three months were observed .ResultsThe overall treatment of minimally invasive soft-channel effective rate of the treatment group was significantly higher than the 92.45% 71.70% small bone window hematoma in the treatment group (P<0.05); mortality minimally invasive soft channel was 3.77% in the treatment group was significantly smaller than the small bone window 9.43% hematoma treatment group (P<0.05); minimally invasive treatment of soft channel group of the assessment of activities of daily living (ADL) after three months, Ⅰ grade was 30 cases, Ⅱ grade was 11 cases, Ⅲ grade was five cases, Ⅳ-Ⅴ was 5 cases, everyday life functional assessment of small bone window hematoma treatment group (ADL), Ⅰ grade was15 cases, Ⅱ grade was18 cases, Ⅲ grade was10 cases, Ⅳ-Ⅴwas 5 cases.Conclusion Under the premise of strictly surgical indications, drilling through minimally invasive treatment of hypertensive basal ganglia hemorrhage can effectively remove intracranial hematoma, thereby reducing brain edema,and operation is simple, safe, which can significantly improve patient outcomes and reduce mortality, morbidity.